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Abstract
Repeated cocaine administration induces behavioral sensiti-
zation and modifications in the phosphorylation pattern of
dopamine and cAMP-regulated phosphoprotein of Mr 32 000
(DARPP-32), characterized by a tonic increase in the Thr75
phosphorylated form, and a decrease in the Thr34 phos-
phorylated form. This study further investigated the correla-
tions between cocaine sensitization and modifications in the
DARPP-32 phosphorylation pattern, cAMP-dependent protein
kinase (PKA) activity, and mGluR5 tone in the medial pre-
frontal cortex and nucleus accumbens. Behavioral sensitiza-
tion and modifications in these neurochemical markers
followed a similar temporal pattern. Moreover, in sensitized
rats acute cocaine administration modified phosphorylation
levels of Thr75- and Thr34-DARPP-32, GluR1, and NR1 sub-
units in the nucleus accumbens only at a dose double the
efficacious dose in control rats. These results suggest that the
high levels of phospho-Thr75 DARPP-32 maintain PKA in a
prevalent inhibited state. Furthermore, in sensitized rats the
acute administration of 6-methyl-2-(phenylethynyl)-pyridine, a
mGluR5 antagonist, reinstated the phosphorylation levels of
Thr75- and Thr34-DARPP-32, GluR1, and NR1 to control
values, and a subsequent cocaine challenge did not elicit a
sensitized response. These data suggest that a tonic increase
in mGluR5 transmission in cocaine-sensitized rats sustains
both the increase in phospho-Thr75 DARPP-32 levels and the
expression of behavioral sensitization.
Keywords: 6-methyl-2-(phenylethynyl)-pyridine, dopamine
and cAMP-regulated phosphoprotein of Mr 32 000, medial
prefrontal cortex, nucleus accumbens.
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The dopamine and cAMP-regulated phosphoprotein of Mr
32 000 (DARPP-32) (Walaas et al. 1983) is enriched in
medium spiny neurons in dorsal and ventral striatum (Ouimet
et al. 1984), where it plays a central role in integrating
dopaminergic and glutamatergic neurotransmission originat-
ing mainly from cortical areas and the substantia nigra pars
compacta/ventral tegmental area, respectively (Greengard
2001). DARPP-32 is a major target protein for the cAMP-
dependent protein kinase (PKA) and its function is deter-
mined by the phosphorylation state. Dopamine, by means of
the D1 receptor-mediated activation of PKA, phosphorylates
DARPP-32 at threonine-34 (Thr-34) and thereby converts
DARPP-32 into a potent inhibitor of protein phosphatase-1
(Hemmings et al. 1984). Phosphorylation at threonine-75
(Thr-75) converts DARPP-32 into an inhibitor of PKA (Bibb
et al. 1999) and antagonizes the PKA/Thr34-DARPP-32/
protein phosphatase-1 cascade. Thus, DARPP-32 can act
either as a phosphatase inhibitor or as a kinase inhibitor,
depending on its relative state of phosphorylation.
Dopamine signaling is crucial in mediating the effects of
psychostimulants such as cocaine (Nestler 2001), and
DARPP-32 is critically involved in these effects. In striatal
regions, acute cocaine administration induces an increase in
DARPP-32 phosphorylation at Thr34 associated with a
relative decrease in Thr75 phosphorylation (Nishi et al.
2000; Rauggi et al. 2005), while repeated administration
induces both behavioral sensitization and a tonic increase in
phospho-Thr75 DARPP-32 levels, associated with a parallel
decrease in phospho-Thr34 DARPP-32 levels (Bibb et al.
2001; Scheggi et al. 2004a,b). Repeated cocaine administra-
tion also induces the accumulation of DFosB in the nucleus
accumbens (NAc) that, in turn, increases the expression of
cyclin-dependent kinase 5 (Cdk5) (Bibb et al. 2001). It has
been reported that Cdk5 plays a counter-adaptive role in both
the development and expression of cocaine-induced self-
administration and behavioral sensitization (Taylor et al.
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2007). Mice carrying a point mutation derived by replacing
the Thr residue with a non-phosphorylatable residue (ala-
nine), at either the 34 or 75 position of DARPP-32, have
been obtained (Svenningsson et al. 2003). An acute cocaine
administration shows attenuated behavioral and neurochem-
ical responses in Thr34 DARPP-32 mutant mice, that upon
repeated cocaine administrations develop behavioral sensiti-
zation (Zachariou et al. 2006). On the contrary, Thr75
DARPP-32 mutant mice show a response to acute cocaine
administration similar to that of wild-type mice, yet they do
not develop behavioral sensitization (Zachariou et al. 2006).
These data support the hypothesis that in cocaine-sensitized
rats the tonic increase in phospho-Thr-75 DARPP-32 levels
and decrease in phospho-Thr-34 DARPP-32 levels in the
NAc is directly related to the condition of behavioral
sensitization (Scheggi et al. 2004a,b).
Cocaine behavioral sensitization is induced and sustained
by a multiplicity of neurochemical mechanisms, in which
dopamine and glutamate play a central role. For example,
NMDA receptor activity controls the development and the
expression of cocaine sensitization (Karler et al. 1989; Wolf
and Jeziorski 1993; Gambarana et al. 1998). Moreover, a
precise interplay between glutamatergic transmission in the
prefrontal cortex and the NAc decreases basal concentra-
tions of extra-neuronal glutamate in the NAc, which results
in a reduced inhibitory tonus of pre-synaptic mGluR2/3 and
a consequent loss of regulatory feedback on synaptic
glutamate release (Kalivas et al. 2003). Thus, lower basal
levels of glutamate, combined with an increased release of
synaptic glutamate in response to activation of prefrontal
cortical afferents to the NAc, seem to underlie acute
cocaine-induced behavioral changes in sensitized animals
such as augmented motor activity (Vanderschuren and
Kalivas 2000), enhanced place conditioning (Shippenberg
et al. 1998), and self-administration relapse (Baker et al.
2003). Different metabotropic glutamate receptors appear to
be involved in these mechanisms (Kalivas 2004; Kenny and
Markou 2004).
Cocaine-induced behavioral sensitization is easily ob-
tained by injecting animals with the drug, and it can be
studied as a phenomenon, independent of the addictive
properties of cocaine. The aim of the present study was to
further characterize the modiﬁcations in DARPP-32/PKA
pathway in cocaine-sensitized rats and to assess whether a
temporal relationship exists between the observed pattern of
neurochemical modiﬁcations and the condition of cocaine
behavioral sensitization. Moreover, we were interested in the
mechanisms that sustain the increased levels of phospho-
Thr75 DARPP-32 in the NAc of cocaine-sensitized rats. As
an increase in phospho-Thr75 DARPP-32 levels has been
associated with type I mGluRs activity in vitro (Liu et al.
2001) and it can be prevented by mGluR5 antagonism in vivo
(Rauggi et al. 2005), we also investigated mGluR5 activity
in cocaine-sensitized rats.
Material and methods
Animals
Experiments were carried out on male Sprague–Dawley rats
(Charles River, Calco, Italy) weighing 125–150 g upon arrival in
the vivarium. Animals were housed ﬁve per cage, kept in an
environment maintained at a constant temperature and humidity
with free access to food and water, and they were moved to a
different cage or apparatus only for the time required for behavioral
manipulation. A 12 h reverse light/dark cycle (7:00 AM lights off,
7 PM lights on) was used. Rats were allowed at least 1 week of
habituation to the animal colony and when experimental procedures
began they weighed 200–225 g. Experiments were carried out from
9:00 AM to 5:00 PM under a red light and controlled noise conditions
in a testing room separated from and adjacent to the main animal
room, under the same conditions of temperature and humidity. The
procedures used in this study were in strict accordance with the
European legislation on the use and care of laboratory animals (EEC
Council Directive 86/609) and were approved by the University of
Siena Ethics Committee.
Induction of cocaine sensitization
In previous studies we used repeated administrations of a high dose
of cocaine to induce sensitization (cocaine 40 mg/kg i.p. on
alternate days · 14 days) (Scheggi et al. 2004a). However, as it
was recently suggested that the modiﬁcations in DARPP-32
phosphorylation pattern observed in sensitized animals could be
related to the high dose of cocaine to which rats were exposed rather
than to the sensitization state (Hope et al. 2005), in the present study
we utilized repeated administrations of a lower dose of cocaine:
10 mg/kg/day i.p. for eight consecutive days. Rats were individually
placed in locomotor activity cages for 35 min after cocaine (or
saline) administration to strengthen environmental contingencies
and to favor the development of sensitization. At the end of the 8-
day protocol, animals were left undisturbed in their home cages for
10 days before the development of behavioral sensitization was
assessed. Rats were then tested for their response to a cocaine
challenge (10 mg/kg, i.p.) and their locomotor activity and
stereotypies were recorded for 30 min (the ﬁrst 5 min after injection
were not taken into account).
The motor activity apparatus had eight compartments
(40 · 45 · 50 cm) into which transparent Perspex cages (height
19 cm, ﬂoor area 23 · 33 cm; Imetronic, Pessac, France) were
placed. Motor activity was detected by a system of infrared photocell
beams; the interruption of two photocell beams was recorded as an
ambulatory activity count. A string of infrared photocell beams,
placed at the height of 15 cm, detected rearing activity. Stereotypies
were scored by an experimenter blind to the experimental condi-
tions, according to a published rating scale (Gambarana et al. 1998).
A cumulative score reﬂecting the intensity of stereotypies during the
30 min observation period was assigned to each rat.
Immunoblotting
Rats were killed and brains were rapidly removed and cut into 1 mm
slices using an ice-cold metal brain matrix (ASI Instruments, Inc.,
Warren, MI, USA). The medial prefrontal cortex (mPFC) and NAc
were quickly dissected out from the slices that had been identiﬁed
using the Atlas of Rat Brain as corresponding to plates 7–9 and
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10–12, respectively (Paxinos and Watson 1998). The ﬁrst slice was
discarded and the mPFC (corresponding to the cingulate area, the
pre-limbic cortex, and part of the infralimbic area) was dissected out
from slice 2, approximately 3.7–2.7 mm from the bregma; the NAc
(corresponding to the NAc shell and core) was dissected out from
slice 3, approximately 2.7–1.7 mm from the bregma, and the anterior
commissura was used as a point of reference (Fig. 1a, b, and c).
Tissues were then ﬂash-frozen in liquid nitrogen and stored
at )80C until assayed. Immunoblotting was performed as already
described (Rauggi et al. 2005). Frozen tissue samples were prepared
by solubilization in boiling 1% sodium dodecyl sulfate and
50 mmol/L NaFl. Aliquots containing 30 lg of total protein were
subjected to sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (12% polyacrylamide gel for DARPP-32 and Cdk5; 7.5%
polyacrylamide gel for a-amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid and NMDA receptor subunits) and transferred to
nitrocellulose membranes. Small aliquots of the homogenate were
retained for protein determination by a modiﬁed Lowry protein assay
method (DC protein assay; BioRad Laboratories, Hercules, CA,
USA) (Lowry et al. 1951). Immunoblotting was carried out with
phosphorylation-state-speciﬁc antibodies against phospho-Thr34
DARPP-32 and phospho-Thr75 DARPP-32 (Cell Signaling Tech-
nology, Beverly, MA, USA), phospho-Ser845 GluR1 and phospho-
Ser897 NR1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or
antibodies that are not phosphorylation-state-speciﬁc against
total DARPP-32 (Cell Signaling Technology), total GluR1 and
NR1 (Santa Cruz Biotechnology), and Cdk5 (Santa Cruz Biotech-
nology). Antibody binding was detected using a chemiluminescence
detection system (Pierce Biotechnology Inc., Rockford, IL, USA)
and quantiﬁed with the Versa Doc 1000 Imaging System (BioRad
Laboratories). Samples containing the same amount of total proteins
from control and treated rats were run on the same immunoblots and
then analyzed together. For each experiment, values obtained from
experimental groups were calculated as the percentage of their
respective control values.
The total amount of DARPP-32 was unmodiﬁed, compared to the
control group, in the mPFC and NAc in all experiments (data not
shown).
(a)
(b) (c)
Fig. 1 Schematic representation, according
to Paxinos and Watson (1998), of levels of
brain slicing (a) for the mPFC (b) and NAc
(c) regions as dissected for immunoblotting.
Cg, cingulate cortex, area 1; PrL, pre-limbic
cortex; IL, infralimbic cortex; fmi, forceps
minor corpus callosum; AcbC, accumbens
nucleus, core; AcbSh, accumbens nucleus,
shell; CPu, caudate putamen; aca, anterior
commissura, anterior part.
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Immunohistochemistry
Immunohistochemistry was performed as previously described
(Scheggi et al. 2004b). Brieﬂy, coronal sections (35 lm), taken
from brain levels corresponding to plates 10–13 of the Atlas of Rat
Brain (Paxinos and Watson 1998), were cut on a cryostat and
collected in cold phosphate-buffered saline (PBS). Free-ﬂoating
sections were pre-treated for 10 min with 1% hydrogen peroxide in
PBS and for 1 h with blocking solution containing 0.2% Triton
X-100 and 2% normal goat serum in PBS. Sections were incubated
at 4C for 48 h with anti-FosB antiserum (1 : 250) (Santa Cruz
Biotechnology) in PBS containing 0.2% Triton X-100 and 2%
normal goat serum. This antibody was raised against an N-terminal
peptide that is common to full-length FosB and DFosB and, in
preliminary immunoblotting experiments, we detected two distinct
immunoreactive bands with an apparent molecular weight of 46 and
32–37 kDA (data not shown), corresponding to full length Fos and
DFosB, respectively (Nakabeppu and Nathans 1991; McClung et al.
2004). After several PBS washes, sections were incubated for 1 h
with biotinylated secondary antibody at 37C (Vectastain Elite-
ABCKit; Vector Laboratories Inc., Burlinghame, CA, USA). After
further PBS washes, sections were incubated with biotin-streptavi-
din-peroxidase complex and the peroxidase reaction product was
visualized by 3,3¢-diaminebenzidine (Vectastain EliteABCKit; Vec-
tor Laboratories Inc.). Sections were mounted onto electrostatic
superfrost glass slides, dehydrated, and coverslipped. FosB/DFosB
positive cells were counted with a light microscope (Eclipse 50i;
Nikon Instruments S.P.A., Sesto Fiorentino, Italy) equipped with a
digital camera (DS-5M; Nikon); using NIH IMAGE software
(Bethesda, MD, USA), a deﬁned square was placed over the NAc
and immunoreactive positive cells were counted by an experimenter
blind to the experimental conditions. To verify the accuracy of
automatic counts, intermittently grains were counted manually.
Bilateral grain counts from three consecutive sections were taken to
obtain the average value from each rat, and sections taken from ﬁve
rats in each experimental group were used.
Experimental protocols
In order to assess whether behavioral expression of sensitization was
a relatively long-lasting phenomenon, and whether deﬁned neuro-
chemical modiﬁcations associated with repeated cocaine exposure
were temporally related to the expression of sensitization, groups of
rats were exposed to the sensitization protocol, and then tested and
killed at different times after the last cocaine exposure. Two different
intervals (washout periods) between assessment of the development
of sensitization and behavioral testing and neurochemical determi-
nations were selected (10 days and 3 months). In order to group
behavioral tests and animal sacriﬁce in a few week interval,
experiment B began about 2 months before experiment A.
Experiment A-1 – Characterization of neurochemical
modifications accompanying the condition of cocaine behavioral
sensitization after a short-term washout
Rats underwent the sensitization protocol (repeated cocaine,
n = 15), or received saline (1 mL/kg/day, i.p., for 8 days, repeated
saline, n = 25). After a 10-day washout, the rats exposed to the
sensitization protocol and 10 rats from the control group were
challenged with cocaine (10 mg/kg, i.p.) to assess the development
of behavioral sensitization. The behavioral response to the challenge
was recorded for 30 min (Table 1). Ten days later, ﬁve rats in the
repeated cocaine group and ﬁve of the repeated saline rats not yet
exposed to cocaine were administered cocaine, ﬁve more rats from
each of these groups were administered saline. Thirty-ﬁve minutes
after cocaine or saline administration, all 20 rats were killed.
In the mPFC and NAc dissected out from brains of repeated
saline and repeated cocaine rats, exposed to saline or cocaine
administration, the phosphorylation pattern of DARPP-32 and the
levels of Cdk5, GluR1 and phospho-GluR1, NR1, and phospho-NR1
were determined. In the remaining repeated saline and repeated
cocaine rats (n = 5 for each group), the expression of DFosB in the
NAc was examined.
Experiment A-2 – Challenge with different doses of cocaine in
sensitized rats: behavioral response and modifications in the
levels of phosphorylation of DARPP-32, and GluR1 and NR1
subunits
Rats were exposed to the cocaine sensitization protocol (repeated
cocaine, n = 15) or to saline treatment (1 mL/kg/day, i.p. for 8 days,
repeated saline, n = 21). After a 10-day washout, the development
Table 1 Behavioral responses to cocaine
challenge
Group n
Stereotypy
score Rearing number
Horizontal
locomotor
activity
Experiment A
1 Repeated saline 10 2.2 ± 0.3 89.5 ± 23.8 117.2 ± 19.0
Repeated cocaine 15 4.4 ± 0.1*** 197.9 ± 9.0*** 543.6 ± 49.3***
2 Repeated saline 6 1.7 ± 0.2 97.0 ± 32.3 167.2 ± 56.6
Repeated cocaine 15 3.9 ± 0.1*** 178.9 ± 24.5 424.7 ± 81.9
3 Repeated saline 5 1.9 ± 0.4 88.4 ± 43.0 105.4 ± 30.4
Repeated cocaine 32 4.4 ± 0.2 149.1 ± 18.8 285.5 ± 50.0
Experiment B
Repeated saline 5 1.9 ± 0.6 77.8 ± 32.2 175.6 ± 31.2
Repeated cocaine 20 4.6 ± 0.1*** 216.5 ± 10.9*** 538.9 ± 53.3**
Repeated saline3m 5 1.5 ± 0.4 153.6 ± 28.1 172.4 ± 39.8
Repeated cocaine3m 8 2.1 ± 0.2
§§§ 190.8 ± 28.4 531.3 ± 87.6*
*p < 0.05, **p < 0.01, ***p < 0.001 compared to the respective repeated saline groups (unpaired
t-test); §§§p < 0.001 compared to the repeated cocaine group.
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of sensitization was ascertained in all rats exposed to the
sensitization protocol and in six repeated saline rats (Table 1). Ten
days later, rats in the repeated cocaine and repeated saline groups
received an acute injection of saline (1 mL/kg) or cocaine (10 or
20 mg/kg), (n = 5 for each subgroup). The behavioral response to
the challenge was recorded and rats were then killed 35 min after the
injection. The DARPP-32 phosphorylation pattern and phospho-
GluR1 and phospho-NR1 levels were determined in the NAc.
Experiment A-3 – Acute mGluR5 inhibition in cocaine-
sensitized rats: behavioral effects and modifications in levels of
phosphorylation of DARPP-32, and GluR1 and NR1 subunits
Rats were exposed to the cocaine sensitization protocol (repeated
cocaine, n = 32) or to saline treatment (1 mL/kg/day, i.p. for 8 days,
repeated saline, n = 28). After a 10-day washout, the development
of sensitization was assessed in all rats exposed to the sensitization
protocol and in a group of ﬁve repeated saline rats (Table 1). Ten
days later, rats in each group were divided into two subgroups, one
receiving a saline injection (1 mL/kg, i.p.) and the other receiving a
selective antagonist of mGluR5 receptors, 6-methyl-2-(phenylethy-
nyl)-pyridine, MPEP (5 mg/kg, i.p.) 1 h before sacriﬁce. Twenty-
ﬁve minutes after saline or MPEP administration, rats in each
subgroup received a saline (1 mL/kg, i.p.) or cocaine injection
(10 mg/kg, i.p.), (n = 4–8 rats in each subgroup of the repeated
saline and repeated cocaine groups) and were placed in the motor
activity apparatus. Locomotor activity and stereotypy scores were
recorded for 30 min, then rats were killed and the pattern of
DARPP-32 phosphorylation and levels of phospho-GluR1 and
phospho-NR1 in the mPFC and NAc were determined. A group of
ﬁve repeated saline rats never exposed to behavioral test were used
as the reference control group for immunoblotting experiments.
The dose of MPEP was selected on the basis of previous studies
(Paterson et al. 2003) and our own study showing that 5 mg/kg of
MPEP did not induce overt modiﬁcations in the spontaneous
behavior of rats (Rauggi et al. 2005).
Experiment B – Assessment of behavioral sensitization to
cocaine and of the neurochemical modifications associated with
repeated cocaine exposure after a long-term washout
Rats underwent either the cocaine sensitization protocol (10 mg/kg/
day, i.p., n = 20) or were treated with saline (1 mL/kg/day, i.p.,
n = 20) for 8 days. After a 10-day washout all cocaine-treated rats
and ﬁve saline-treated rats were challenged with cocaine (10 mg/kg,
i.p.) and motor activity and stereotypy scores were determined
(Table 1). Then, rats that had developed sensitization (repeated
cocaine3m, n = 20) and the saline-treated control rats never exposed
to cocaine (repeated saline3m, n = 15) were kept in the vivarium for
3 months, where they underwent frequent handling. At the end of
this period, to verify whether behavioral sensitization was still fully
expressed in previously sensitized rats, eight rats in the repeated
cocaine3m group, and ﬁve rats in the repeated saline3m group
underwent a cocaine challenge (10 mg/kg, i.p.). Thirty-ﬁve minutes
after cocaine administration rats in the two groups were killed, along
with ﬁve repeated saline3m and ﬁve repeated cocaine3m rats not
exposed to the ﬁnal cocaine challenge. The mPFC and NAc were
dissected out to determine the phosphorylation pattern of DARPP-
32 and the levels of Cdk5, GluR1 and phospho-GluR1, NR1, and
phospho-NR1. The remaining repeated saline3m and repeated
cocaine3m rats not exposed to the cocaine challenge (n = 5 for
each group) were killed at the same time as ﬁve rats in the repeated
saline and ﬁve rats in the repeated cocaine groups from the short-
term washout experiment (experiment A) and the expression of
DFosB in the NAc was examined in the four groups.
Drugs
Cocaine and MPEP were dissolved in deionized/distilled water and
injected in a volume of 1 mL/kg rat body weight. Cocaine was
purchased from Macfarlan Smith Limited (Edinburgh, UK) and
MPEP from Tocris Cookson Ltd (Avonmouth, UK). All chemicals
were purchased from commercial sources.
Statistical analysis
Statistical analyses were performed using commercially available
software (Prism 4.0a, GraphPad Software Inc., San Diego, CA,
USA). All data are expressed as mean ± SEM. Statistical compar-
isons of behavioral measures were made by unpaired t-test or, when
more than two groups were analyzed, by ANOVA followed by
Dunnett’s test when p < 0.05. Western blot and immunohistochem-
ical data were analyzed using ANOVA and post hoc analysis was
performed by Bonferroni’s test when p < 0.05, unless otherwise
speciﬁed.
Results
Experiment A-1 – Characterization of neurochemical
modifications accompanying the condition of cocaine
behavioral sensitization
Rats exposed to the protocol of cocaine sensitization and rats
in the control group received a cocaine challenge after a
10-day washout. The challenge elicited an intense motor
response in rats exposed to the sensitization protocol:
stereotypy scores and locomotor activity were signiﬁcantly
higher in this group (repeated cocaine) than in the repeated
saline group (p < 0.001 for stereotypy scores, rearing
number, and horizontal locomotion, unpaired t-test; Table 1).
This experiment was aimed at examining a pattern of
neurochemical modiﬁcations that accompany the behavioral
expression of cocaine sensitization after a short-term washout.
Moreover, to examine whether some of the neurochemical
variables studied (phosphorylation pattern of DARPP-32,
phosphorylation levels of GluR1, and NR1 subunits) would
change in response to acute cocaine administration in
sensitized rats as they do in control rats, ﬁve animals in the
repeated saline and repeated cocaine groups were exposed to
a cocaine challenge and then killed 35 min later.
Western blot analysis in the mPFC: DARPP-32
phosphorylation pattern
In the mPFC, phospho-Thr75 DARPP-32 levels were
signiﬁcantly different between rats in the repeated saline
and repeated cocaine groups (F3,19 = 19.22, p < 0.001).
Post hoc analysis demonstrated that in repeated saline and
1172 S. Scheggi et al.
Journal Compilation  2007 International Society for Neurochemistry, J. Neurochem. (2007) 103, 1168–1183
 2007 The Authors
repeated cocaine rats not exposed to the cocaine challenge,
phospho-Thr75 DARPP-32 levels were higher in the
repeated cocaine group (p < 0.05). After the challenge,
phospho-Thr75 DARPP-32 levels decreased in the repeated
saline group and in the repeated cocaine group, compared to
their respective saline-treated groups (p < 0.001 and
p < 0.01, respectively; Fig. 2a). Phospho-Thr34 DARPP-32
levels were signiﬁcantly different between groups
(F3,19 = 22.76; p < 0.001), and post hoc analysis demon-
strated that in rats not exposed to the challenge phospho-
Thr34 DARPP-32 levels were lower in the repeated cocaine
group compared to the repeated saline group (p < 0.05).
After cocaine challenge, phospho-Thr34 DARPP-32 levels
increased in the repeated saline and in the repeated cocaine
group, compared to their respective saline-treated groups
(p < 0.001 and p < 0.05, respectively; Fig. 2b). The phos-
phorylation levels of two other PKA substrates, GluR1 and
NR1 subunits, were then measured.
Levels of GluR1 and NR1 subunits and of their
phosphorylated forms
The levels of GluR1 and NR1 subunits were similar in rats in
the repeated cocaine and repeated saline groups (GluR1,
repeated cocaine = 102.3 ± 7.4% of repeated saline group;
NR1, repeated cocaine = 111.8 ± 10.6% of repeated saline
group, unpaired t-test). GluR1 and NR1 subunit phosphory-
lation levels in rats of the repeated saline and repeated
cocaine groups, administered saline or cocaine, were
different (phospho-GluR1, F3, 19 = 17.58, p < 0.001;
phospho-NR1, F3, 19 = 18.21, p < 0.001). In particular, in
saline-treated rats, phospho-GluR1 and phospho-NR1 levels
were lower in the repeated cocaine group than in the
repeated saline group (phospho-GluR1, p < 0.05; phospho-
NR1, p < 0.01; Fig. 2c and d). After cocaine challenge, the
levels of phosphorylation of the GluR1 and NR1 subunits
increased in both repeated saline and repeated cocaine
groups, compared to their respective saline-treated groups
(phospho-GluR1, p < 0.01 for the repeated saline group,
p < 0.05 for the repeated cocaine group; phospho-NR1,
p < 0.01 for the repeated saline group, p < 0.05 for the
repeated cocaine group; Fig. 2c and d).
Cdk5 levels
As repeated cocaine administration increases Cdk5 expres-
sion in striatal areas, we investigated the existence of a
possible link between this increase and the condition of
cocaine sensitization. After a 10-day washout, the levels of
expression of Cdk5 were higher in rats in the repeated
cocaine group than in rats in the repeated saline group
(repeated cocaine = 138 + 4.8% of control value, p < 0.001,
unpaired t-test).
Western blot analysis in the NAc: DARPP-32
phosphorylation pattern
In the NAc, levels of phospho-Thr75 DARPP-32 showed a
signiﬁcant difference between groups (F3,19 = 56.45,
p < 0.001). In saline-treated rats, phospho-Thr75 DARPP-
32 levels were higher in the repeated cocaine group than in
the repeated saline group (p < 0.001; Fig. 3a). In rats
exposed to the challenge, levels of phospho-Thr75 DAR-
PP-32 decreased in the repeated saline group (p < 0.001),
but were unmodiﬁed in the repeated cocaine group,
(a) (b)
(c) (d)
Fig. 2 Levels of phospho-Thr75 and
phospho-Thr34 DARPP-32, phospho-
GluR1, and phospho-NR1 in the mPFC of
control (repeated saline) and cocaine-sen-
sitized (repeated cocaine) rats, after a sal-
ine (1 mL/kg) or cocaine (10 mg/kg, i.p.)
challenge, administered after a 10-day
washout. Levels of phospho-Thr75 DARPP-
32 (a), phospho-Thr34 DARPP-32 (b),
phospho-GluR1 (c), and phospho-NR1 (d),
shown in graphical format in the upper
panels, are expressed as mean ± SEM
percentage of values in the saline-treated
control group. Representative immunoblots
are presented in the lower panels.
***p < 0.001, **p < 0.01, *p < 0.05 versus
the saline-treated repeated saline group;
§p < 0.05, §§p < 0.01 versus the saline-
treated repeated cocaine group (Bonfer-
roni’s test).
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compared to their respective saline-treated groups (Fig. 3a).
Levels of phospho-Thr34 DARPP-32 were also signiﬁcantly
different between groups (F3,19 = 44.77, p < 0.001). In
saline-treated rats, phospho-Thr34 DARPP-32 levels were
lower in the repeated cocaine group than in the repeated
saline group (p < 0.01; Fig. 3b). Moreover, in rats exposed
to cocaine challenge, levels of phospho-Thr34 DARPP-32
increased in the repeated saline group (p < 0.001), but not in
the repeated cocaine group, compared to their respective
saline-treated groups (Fig. 3b).
Levels of GluR1 and NR1 subunits and of their
phosphorylated forms
The expression of both GluR1 and NR1 subunits was
higher in rats in the repeated cocaine group than in rats in
the repeated saline group (p < 0.01 and p < 0.01, respec-
tively, unpaired t-test; Fig. 3c and d). One-way ANOVA
analysis of the phosphorylation levels of GluR1 and NR1
in rats of the repeated saline and repeated cocaine groups
indicated a signiﬁcant difference between groups for both
phosphorylated subunits (phospho-GluR1, F3,19 = 30.53,
p < 0.001; phospho-NR1, F3,19 = 25.68, p < 0.001). In
particular, in saline-treated rats, phospho-GluR1, and
phospho-NR1 levels were lower in the repeated cocaine
group than in the repeated saline group (phospho-GluR1,
p < 0.05; phospho-NR1, p < 0.05; Fig. 3e and f). After
cocaine challenge, the levels of the phosphorylated GluR1
and NR1 subunits increased in rats of the repeated saline
group, compared to their saline-treated group (p < 0.001
for both phospho-GluR1 and phospho-NR1), but they were
unchanged in rats of the repeated cocaine group (Fig. 3e
and f).
Cdk5 levels
Levels of expression of Cdk5 in the NAc were higher in rats
in the repeated cocaine group than rats in the repeated saline
group (repeated cocaine = 163 + 13.3% of control value,
p < 0.01, unpaired t-test).
The results of experiment A-1 showed consistent modiﬁ-
cations in the phosphorylation pattern of DARPP-32, GluR1
and NR1 subunits, and in Cdk5 levels in the mPFC and NAc
of sensitized rats after a 10-day washout. Moreover, another
hallmark of the condition of cocaine sensitization emerged,
i.e. the lack of effect of an acute cocaine administration on
the phosphorylation levels of DARPP-32, GluR1, and NR1 in
the NAc.
(a) (b)
(c) (d)
(e) (f)
Fig. 3 Levels of phospho-Thr75 and
phospho-Thr34 DARPP-32, GluR1, NR1,
phospho-GluR1, and phospho-NR1 in the
NAc of control (repeated saline) and co-
caine-sensitized (repeated cocaine) rats,
after a saline (1 mL/kg) or cocaine (10 mg/
kg, i.p.) challenge, administered after a 10-
day washout. Levels of phospho-Thr75
DARPP-32 (a), phospho-Thr34 DARPP-32
(b), GluR1 (c), NR1 (d), phospho-GluR1 (e),
and phospho-NR1 (f) are expressed as
mean ± SEM percentage of values in the
saline-treated control group. Representa-
tive immunoblots are presented in the lower
panels. ***p < 0.001, **p < 0.01, *p < 0.05
versus the saline-treated repeated saline
group (Bonferroni’s test).
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Experiment A-2 – Challenge with different doses of
cocaine in sensitized rats: behavioral response and
modifications in the levels of phosphorylation of
DARPP-32, and GluR1 and NR1 subunits
In order to examine whether the lack of modiﬁcations in
DARPP-32 phosphorylation pattern after an acute cocaine
challenge was the expression of reduced responsiveness of
the dopamine D1 receptor/cAMP/PKA pathway to increased
dopamine levels, 10 days after the assessment of sensitiza-
tion (Table 1), sensitized and control rats were challenged
with saline (1 mL/kg) or cocaine (10 or 20 mg/kg i.p.) and
then killed 35 min after injection. At the dose of 10 mg/kg,
cocaine induced higher stereotyped and locomotor activity in
sensitized rats than in control rats, as expected. At the dose of
20 mg/kg, cocaine elicited similar stereotyped and locomotor
activity in rats in the repeated saline and repeated cocaine
groups (data not shown).
Levels of expression and/or phosphorylation of DARPP-
32, GluR1, and NR1 were determined only in the NAc. In
order to conﬁrm that these variables were modiﬁed in
cocaine-sensitized rats, as observed in experiment A-1,
western blot data of all the six groups were analyzed by
ANOVA and when p < 0.05 Bonferroni’s test was used to
assess whether the levels of the variables studied were
different between the repeated saline and repeated cocaine
saline-treated groups. Data were then recalculated in order to
express levels in the repeated saline and repeated cocaine
challenged groups as 100% of their respective controls (the
saline-treated group), and then analyzed by ANOVA and post
hoc Dunnett’s test. Analysis of phospho-Thr75 DARPP-32
levels in all six subgroups of rats showed a signiﬁcant
difference (F5,29 = 36.48, p < 0.001); in particular, post hoc
analysis conﬁrmed that in saline-treated rats levels of
phospho-Thr75 DARPP-32 were higher in the repeated
cocaine than in the repeated saline group (p < 0.001). When
data were recalculated in order to express phospho-Thr75
DARPP-32 levels in the repeated saline and repeated
cocaine challenged groups as the percentage of their
respective controls (the saline-treated groups), statistical
analysis indicated a signiﬁcant difference between phospho-
Thr75 DARPP-32 levels in the three subgroups of repeated
saline rats (F2,14 = 34.53, p < 0.001; Fig. 4a). In fact, acute
cocaine administration induced a decrease in phospho-Thr75
DARPP-32 levels compared to levels in saline-treated rats,
and this effect was already maximal at the 10 mg/kg dose
(p < 0.01, for both the 10 and 20 mg/kg cocaine doses;
(a) (b)
(c) (d)
Fig. 4 Levels of phospho-Thr75 and phospho-Thr34 DARPP-32,
phospho-GluR1, and phospho-NR1 in the NAc of control (repeated
saline) and cocaine-sensitized (repeated cocaine) rats, after a saline
(1 mL/kg) or cocaine (10 or 20 mg/kg, i.p.) challenge, administered
after a 10-day washout. Levels of phospho-Thr75 DARPP-32 (a),
phospho-Thr34 DARPP-32 (b), phospho-GluR1 (c), and phospho-NR1
(d) are expressed as mean ± SEM percentage of values in the saline-
treated respective control groups. Representative immunoblots are
presented in the lower panels. **p < 0.01, *p < 0.05 versus the saline-
treated respective control groups (Bonferroni’s test).
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Fig. 4a). In rats in the repeated cocaine group, a signiﬁcant
difference in the levels of phospho-Thr75 DARPP-32 was
demonstrated between subgroups (F2,14 = 8.25, p < 0.01;
Fig. 4a). As observed in the previous experiment, the 10 mg/
kg cocaine challenge did not modify the pattern of DARPP-
32 phosphorylation in sensitized rats. However, after the
20 mg/kg cocaine challenge, phospho-Thr75 DARPP-32
levels decreased compared to levels in the saline-treated
subgroup (p < 0.01; Fig. 4a). Phospho-Thr34 DARPP-32
levels in the six subgroups of rats were signiﬁcantly different
(F5,29 = 31.14, p < 0.001); in particular, post hoc analysis
conﬁrmed that levels of phospho-Thr34 DARPP-32 were
lower in the repeated cocaine than in the repeated saline
group (p < 0.001). When data were recalculated in order to
express phospho-Thr34 DARPP-32 levels in the repeated
saline and repeated cocaine challenged groups as the
percentage of their respective saline-treated groups, statistical
analysis indicated a signiﬁcant difference in phospho-Thr34
DARPP-32 levels in the three subgroups of repeated saline
rats (F2,14 = 14.42, p < 0.001). Acute cocaine administration
induced an increase in phospho-Thr34 DARPP-32 levels
compared to levels in the repeated saline saline-treated rats,
and this effect was already maximal at the 10 mg/kg dose
(p < 0.01 for both doses; Fig. 4b). In rats in the repeated
cocaine group, a signiﬁcant difference in the levels of
phospho-Thr34 DARPP-32 was also demonstrated between
subgroups (F2,14 = 20.51, p < 0.001). As observed in the
previous experiment, the 10 mg/kg cocaine challenge did not
modify phospho-Thr34 DARPP-32 levels in cocaine-sensi-
tized rats. However, after the 20 mg/kg cocaine challenge,
levels of phospho-Thr34 DARPP-32 increased compared to
levels in the repeated cocaine saline-treated subgroup
(p < 0.01; Fig. 4b).
The levels of phospho-GluR1 and phospho-NR1 subunits
in the repeated saline group were signiﬁcantly different
between subgroups (phospho-GluR1, F5,29 = 38.85,
p < 0.001; phospho-NR1, F5,27 = 73.29, p < 0.001); in par-
ticular, post hoc analysis conﬁrmed that levels of both
phosphorylated subunits were higher in the repeated saline
than in the repeated cocaine group (phospho-GluR1,
p < 0.05; phospho-NR1, p < 0.001). When data were recal-
culated, statistical analysis indicated a signiﬁcant difference
in levels of phospho-GluR1 and phospho-NR1 in the three
subgroups of repeated saline rats (phospho-GluR1, ANOVA,
F2,14 = 28.49, p < 0.001; phospho-NR1, F2,13 = 51.48,
p < 0.001). In rats in the repeated saline group, acute
cocaine administration induced an increase in phospho-
GluR1 and phospho-NR1 levels, compared to levels in the
saline-treated rats, and this effect was already maximal at the
10 mg/kg dose (for both doses, phospho-GluR1, p < 0.01
and phospho-NR1, p < 0.01; Fig. 4c and d). In rats in
the repeated cocaine group, signiﬁcant differences were
observed in the levels of phospho-GluR1 and phospho-NR1
between different subgroups (phospho-GluR1, F2,14 = 30.20,
p < 0.001; phospho-NR1, F2,12 = 4.56, p < 0.05) and, as
observed with the DARPP-32 phosphorylation pattern,
modiﬁcations in the levels of phosphorylated subunits were
present only after the 20 mg/kg cocaine dose (phospho-
GluR1, p < 0.01, phospho-NR1, p < 0.05; Fig. 4c and d).
These results indicated an increased threshold of PKA-
mediated phosphorylation of Thr34 DARPP-32, GluR1, and
NR1 in the NAc of sensitized rats, possibly related to the
steadily increased levels of phospho-Thr75 DARPP-32.
Experiment A-3 – Acute mGluR5 inhibition in cocaine-
sensitized rats: behavioral effects and modifications in
levels of phosphorylation of DARPP-32, GluR1 and NR1
subunits
In order to investigate whether the expression of a sensitized
behavioral response to cocaine and the steady increase in
phospho-Thr75 DARPP-32 levels in sensitized rats was
related to sustained mGluR5 activity, a selective antagonist
of mGluR5s, MPEP, was acutely administered to control and
cocaine-sensitized rats. When MPEP (5 mg/kg, i.p.) was
administered, 10 days after the assessment of sensitization
(Table 1), it did not modify the motility of rats in the
repeated saline and repeated cocaine groups. Moreover,
when cocaine (10 mg/kg, i.p.) was administered after MPEP,
the expression of stereotypies and the increase in rearings
were prevented in cocaine-sensitized, but not in control, rats
(Table 2). Data were analyzed by ANOVA (stereotypy score:
F6,43 = 11.89, p < 0.001; rearing number: F6,43 = 3.88,
p < 0.01; horizontal locomotor activity: F6,43 = 3.73,
p < 0.01), followed by Dunnett’s test using the repeated
saline rats receiving saline as the control group. This analysis
conﬁrmed the sensitized response to cocaine in the repeated
cocaine group and showed an increase in stereotypies and
motor activity in the repeated saline group (Table 2).
Subsequently, the data relative to the repeated saline group
and the repeated cocaine group were analyzed separately by
ANOVA followed by Dunnett’s test, using the respective
saline + cocaine-treated group as the reference group. This
analysis conﬁrmed that MPEP administration before cocaine
injection prevented the increase in stereotypies and rearings
in cocaine-sensitized rats (stereotypy score p < 0.05; rearing
number p < 0.01).
The pattern of DARPP-32 phosphorylation and the levels
of phospho-GluR1, and phospho-NR1 were examined in the
mPFC and NAc of rats in the repeated saline and repeated
cocaine groups acutely administered saline (1 mL/kg, i.p.),
or the mGluR5 antagonist, MPEP (5 mg/kg, i.p.). In the
mPFC, phospho-Thr75 DARPP-32 levels differed between
groups (F3,18 = 22.53, p < 0.001). Bonferroni’s post hoc
analysis demonstrated that in the repeated saline group
phospho-Thr75 DARPP-32 levels decreased after MPEP
administration (repeated saline + MPEP = 80.4 ± 4.8% of
repeated saline, p < 0.01). Moreover, in the repeated
cocaine group, phospho-Thr75 DARPP-32 levels decreased
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after MPEP administration to levels similar to those ob-
served in the repeated saline group (repeated cocaine =
124.8 ± 5.7% and repeated cocaine + MPEP = 105.6 ±
2.7% of repeated saline, repeated cocaine vs. repeated
cocaine + MPEP p < 0.01). Phospho-Thr34 DARPP-32 lev-
els differed between groups (F3,19 = 7.84, p < 0.01), and
post hoc analysis demonstrated that 1 h after MPEP admin-
istration, phospho-Thr34 DARPP-32 levels had increased in
repeated cocaine rats to levels similar to those observed in
repeated saline rats (repeated saline + MPEP = 120.2 ±
11.8%, repeated cocaine = 80.4 ± 2.5%, repeated cocai-
ne + MPEP = 113.8 ± 3.6% of repeated saline; repeated
cocaine vs. repeated cocaine + MPEP = p < 0.01). Levels
of phospho-GluR1 and phospho-NR1 subunits differed
between groups (phospho-GluR1, F3,18 = 26.52, p < 0.001;
phospho-NR1, F3,19 = 9.13, p < 0.001). In particular, post
hoc analysis demonstrated that phospho-GluR1 levels had
increased in repeated saline rats after MPEP administration
(133.3 ± 6.6% of saline-treated rats in the repeated saline
group, p < 0.001), and a similar modiﬁcation was observed
in phospho-NR1 levels (124.6 ± 8.5% of saline-treated rats,
p < 0.05). In rats of the repeated cocaine group, levels of
phospho-GluR1 subunit increased after MPEP administration
(108.2 ± 4.0% vs. 83.4 ± 3.5% in saline-treated repeated
cocaine rats, p < 0.001), and they were similar to repeated
saline group levels. Similarly, phospho-NR1 levels increased
in rats of the repeated cocaine group after MPEP adminis-
tration to levels similar to those observed in the repeated
saline group (113.0 ± 8.1% vs. 81.8 ± 3.0% in saline-treated
repeated cocaine rats, p < 0.01).
In the NAc, phospho-Thr75 DARPP-32 levels differed
between groups (F3,19 = 18.11, p < 0.001) and post hoc
Bonferroni’s test demonstrated that levels were unmodiﬁed
after MPEP administration in the repeated saline group;
phospho-Thr75 DARPP-32 levels were lower in the repeated
cocaine group after MPEP administration than in repeated
cocaine rats receiving saline (p < 0.001), and similar to
levels in repeated saline rats (99.2 ± 3.5% of repeated saline
group; Fig. 5a). Phospho-Thr34 DARPP-32 levels were
different between groups (F3,19 = 8.04, p < 0.01) and
post hoc analysis demonstrated that they were unmodiﬁed
after MPEP administration in repeated saline rats (Fig. 5b).
In repeated cocaine rats, phospho-Thr34 DARPP-32 levels
increased 1 h after MPEP administration (p < 0.01) and were
similar to levels in repeated saline rats (99.8 ± 6.45% of
repeated saline group; Fig. 5b).
Levels of phospho-GluR1 and phospho-NR1 subunits in
the NAc differed between groups (phospho-GluR1,
F3,19 = 35.06, p < 0.001; phospho-NR1, F3,19 = 11.86,
p < 0.001). Post hoc analysis demonstrated that in repeated
saline rats, phospho-GluR1 levels increased after MPEP
administration (p < 0.001), while phospho-NR1 levels were
unmodiﬁed (Fig. 5c and d). On the other hand, in repeated
cocaine rats, levels of phospho-GluR1 and phospho-NR1
subunits increased after MPEP administration (p < 0.001 for
both phospho-GluR1 and phospho-NR1; Fig. 5c and d).
These results showed that the acute administration of an
mGluR5 antagonist reduced the expression of a sensitized
response to a cocaine challenge and restored a pattern of
DARPP-32, GluR1, and NR1 phosphorylation similar to that
observed in control rats.
Experiment B – Assessment of behavioral sensitization to
cocaine and of the neurochemical modifications
associated to repeated cocaine exposure after a long-term
washout
This experiment was aimed at verifying whether the
observed neurochemical modiﬁcations associated to the
expression of cocaine sensitization after a short-term washout
were temporally related to behavioral sensitization. Thus,
behavioral sensitization and the neurochemical variables
studied after a short-term washout were determined after a
3-month washout in rats that had fully expressed behavioral
sensitization after a 10-day washout.
In order to assess the development of sensitization, rats
exposed to the sensitization protocol and rats from the saline-
treated group were challenged with cocaine after a 10-day
washout. As expected, cocaine-treated rats exhibited a
sensitized response to the challenge (Table 1). However,
when a subgroup of sensitized rats was challenged again
Table 2 Behavioral responses to cocaine
challenge after saline or MPEP administra-
tion
Group Treatment n
Stereotypy
score
Rearing
number
Horizontal
locomotor
activity
Repeated saline Saline + saline 5 0.5 ± 0.1 19.6 ± 5.0 61.8 ± 22.81
Saline + cocaine 7 2.4 ± 0.5§ 179.6 ± 54.7§ 423.4 ± 117.7§
MPEP + cocaine 6 1.8 ± 0.4 110.0 ± 46.5 209.6 ± 40.5
MPEP + saline 4 0.6 ± 0.2 21.0 ± 5.3 56.5 ± 17.6*
Repeated cocaine Saline + cocaine 8 4.1 ± 0.3§§ 172.0 ± 18.3§ 374.9 ± 67.4
MPEP + cocaine 8 2.6 ± 0.5§§* 78.9 ± 26.5** 358.8 ± 125.5
MPEP + saline 5 0.4 ± 0.2** 25.6 ± 10.9** 39.4 ± 20.4
§p < 0.05, §§p < 0.01 compared to the Repeated saline – Saline + saline group; *p < 0.05,
**p < 0.01 compared to the respective Saline + cocaine groups (ANOVA followed by Dunnett’s test).
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3 months later (repeated cocaine3m group), the horizontal
locomotion score was higher than that in the repeated
saline3m group (p < 0.05, unpaired t-test), but the stereotypy
scores and number of rearings were similar to those of
repeated saline3m group (Table 1). Thus, behavioral sensiti-
zation was still present after a 3-month washout, but it was
less strongly expressed than after a short-term washout.
Western blot analysis was then carried out in rats in the
repeated saline3m and repeated cocaine3m groups, exposed
to saline or cocaine treatment before sacriﬁce.
Western blot analysis in the mPFC: DARPP-32
phosphorylation pattern
In the mPFC, a signiﬁcant difference in phospho-Thr75
DARPP-32 levels was observed between groups
(F3,19 = 10.96, p < 0.001). Post hoc analysis demonstrated
that in saline-treated rats, phospho-Thr75 DARPP-32 levels
were similar in the two groups. After cocaine challenge,
phospho-Thr75 DARPP-32 levels decreased in the repeated
saline3m and repeated cocaine3m groups, compared to their
respective saline-treated groups (p < 0.01 and p < 0.05,
respectively; Table 3). Phospho-Thr34 DARPP-32 levels
differed signiﬁcantly between groups (F3,17 = 13.46;
p < 0.001); they were similar in saline-treated rats and after
cocaine administration they were signiﬁcantly increased in
the repeated saline3m and repeated cocaine3m groups,
compared to their respective saline-treated groups
(p < 0.001 and p < 0.05, respectively; Table 3).
Levels of GluR1 and NR1 subunits and of their
phosphorylated forms
Analysis of the levels of GluR1 and NR1 subunits was not
performed in the mPFC, as the expression of both subunits
was unchanged in this region in control and sensitized rats
after a 10-day washout. Phosphorylation levels of GluR1 and
NR1 were examined in rats in the repeated saline3m and
repeated cocaine3m groups exposed to saline or cocaine
administration. The levels of both phosphorylated subunits
differed signiﬁcantly between groups (phospho-GluR1,
F3,19 = 8.74, p < 0.01; phospho-NR1, F3,16 = 15.92, p <
0.001; Table 3). Post hoc analysis demonstrated that in
saline-treated rats, levels of phospho-GluR1 and phospho-
NR1 were similar in the two groups. After cocaine challenge,
levels of phospho-GluR1 signiﬁcantly increased in both the
repeated saline3m and repeated cocaine3m groups compared
to their respective saline-treated groups (p < 0.01 for the
(a) (b)
(c) (d)
Fig. 5 Levels of phospho-Thr75 and phospho-Thr34 DARPP-32,
phospho-GluR1, and phospho-NR1 in the NAc of control (repeated
saline) and cocaine-sensitized (repeated cocaine) rats, after a saline
(1 mL/kg) or MPEP (5 mg/kg, i.p.) administration after a 10-day
washout. Levels of phospho-Thr75 DARPP-32 (a), phospho-Thr34
DARPP-32 (b), phospho-GluR1 (c), and phospho-NR1 (d) are
expressed as mean ± SEM percentage of values in the saline-treated
control group. Representative immunoblots are presented in the lower
panels. ***p < 0.001, **p < 0.01, *p < 0.05 versus the saline-treated
repeated saline group; §§§p < 0.001, §§p < 0.01 versus the saline-
treated repeated cocaine group (Bonferroni’s test).
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repeated saline3m group and p < 0.05 for the repeated
cocaine3m group; Table 3). Phospho-NR1 levels were also
signiﬁcantly increased in the repeated saline3m group and in
the repeated cocaine3m group compared to their respective
saline-treated groups (p < 0.001 for the repeated saline3m
group and p < 0.01 for the repeated cocaine3m group;
Table 3).
Cdk5 levels
After a 3-month washout, Cdk5 levels were similar in the
repeated saline3m and repeated cocaine3m groups (Table 3).
These results demonstrated that in the mPFC of sensitized
rats, after a 3-month washout, Thr75 DARPP-32, Thr34
DARPP-32, GluR1, and NR1 phosphorylation levels, as well
as Cdk5 levels, were similar to those of age-matched control
rats.
Western blot analysis in the NAc: DARPP-32
phosphorylation pattern
In the NAc, phospho-Thr75 DARPP-32 levels differed
signiﬁcantly between groups (F3,19 = 19.21, p < 0.001).
Post hoc analysis demonstrated that in saline-treated rats,
phospho-Thr75 DARPP-32 levels were similar in the two
groups. After acute cocaine administration, phospho-Thr75
DARPP-32 levels decreased in the repeated saline3m and
repeated cocaine3m groups, compared to levels in their
respective saline-treated groups (p < 0.001 and p < 0.05,
respectively; Table 3). Phospho-Thr34 DARPP-32 levels
were also signiﬁcantly different between groups
(F3,19 = 18.77, p < 0.001). In saline-treated rats, levels in
the repeated cocaine3m group were similar to levels in the
repeated saline3m group. After acute cocaine, phospho-Thr34
DARPP-32 levels increased in the repeated saline3m group
compared to the saline-treated repeated saline3m rats
(p < 0.001), while in the repeated cocaine3m group they
were similar to the levels in saline-treated repeated cocaine3m
rats (Table 3).
Levels of GluR1 and NR1 subunits and of their
phosphorylated forms
Analysis of the levels of GluR1 and NR1 subunits indicated
that the expression of both subunits was similar in rats in the
repeated saline3m and in the repeated cocaine3m groups
(Table 3). Analysis of phosphorylation levels of GluR1 and
NR1 subunits in rats in the repeated saline3m and repeated
cocaine3m groups indicated a signiﬁcant difference between
groups (phospho-GluR1, F3,19 = 17.90, p < 0.001; phospho-
NR1, F3,19 = 19.90, p < 0.001). In saline-treated rats,
phospho-GluR1 and phospho-NR1 levels were similar in
the repeated saline3m and repeated cocaine3m groups
(Table 3). After acute cocaine challenge, phospho-GluR1
and phospho-NR1 levels increased in both the repeated
saline3m and repeated cocaine3m groups, compared to the
levels in their respective saline-treated groups (phospho-
GluR1 and phospho-NR1, p < 0.001 repeated saline3m and
p < 0.05 for the repeated cocaine3m group; Table 3).
Table 3 Neurochemical modifications
associated to repeated cocaine exposure
after a 3-month washout
Repeated
saline3m
Repeated
saline3m +
cocaine
Repeated
cocaine3m
Repeated
cocaine3m +
cocaine
mPFC
Thr75-DARPP32 100 70.6 ± 5.4** 107.0 ± 7.1 83.8 ± 4.3§
Thr34-DARPP32 100 134.0 ± 3.2*** 98.25 ± 4.8 119.8 ± 6.7*
pGluR1 100 135.0 ± 7.7** 103.0 ± 5.3 126.2 ± 7.0
§
pNR1 100 130.8 ± 4.9*** 106.8 ± 3.0 124.8 ± 4.0
§§
Cdk5 100 ND 105.5 ± 3.5 ND
NAc
Thr75-DARPP32 100 51.8 ± 4.6*** 109.0 ± 8.0 83.0 ± 6.9§
Thr34-DARPP32 100 184.0 ± 12.1*** 100.4 ± 8.1 125.2 ± 10.9
GluR1 100 ND 94.4 ± 3.5 ND
NR1 100 ND 82.2 ± 9.7 ND
pGluR1 100 185.8 ± 15.2*** 108.6 ± 2.1 144.6 ± 10.3
§
pNR1 100 174.0 ± 14.0*** 103.4 ± 4.1 139.6 ± 5.6
§
Cdk5 100 ND 106 + 6.0 ND
Levels of phospho-Thr75 and phospho-Thr34 DARPP-32, GluR1, NR1, phospho-GluR1, phospho-
NR1 and Cdk5 in the mPFC and NAc of control (repeated saline3m) and cocaine-sensitized
(repeated cocaine3m) rats, after a saline (0.1 mL/kg) or cocaine (10 mg/kg, i.p.) challenge,
administered after a 3-month washout. Levels of phospho-Thr75 and phospho-Thr34 DARPP-32,
GluR1, NR1, phospho-GluR1, phospho-NR1, and Cdk5 are expressed as mean ± SEM percentage
of levels in the saline-treated control (repeated saline3m) rats. ***p < 0.001, **p < 0.001, *p < 0.05
versus the saline-treated repeated saline3m group;
§§p < 0.001, §p < 0.05 versus the saline-treated
repeated cocaine3m group.
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Cdk5 levels
After a 3-month washout, Cdk5 levels in the NAc were
similar in the repeated saline3m and repeated cocaine3m
groups (Table 3).
The results of experiment B indicated that, in the NAc of
rats fully sensitized after a short-term washout, neurochem-
ical variables were in part similar to control group values
after a 3-month washout: i.e. phospho-Thr75 DARPP-32,
phospho-Thr34 DARPP-32, GluR1, NR1, phospho-GluR1,
phospho-NR1, and Cdk5 levels in saline-treated rats were
similar in the repeated cocaine3m and repeated saline3m
groups. After cocaine challenge, phospho-Thr75 DARPP-32,
phospho-GluR1, and phospho-NR1 levels changed in the
same directions as in the repeated saline3m group, although
to a lesser extent (repeated cocaine3m vs. repeated saline3m
p < 0.01 for phospho-Thr75 DARPP-32, p < 0.05 for both
phospho-GluR1 and phospho-NR1), while phospho-Thr34
DARPP-32 levels were unmodiﬁed.
Expression of DFosB after a short- and long-term
washout period
In order to study whether modiﬁcations in DFosB levels
followed a similar temporal pattern of the behavioral
expression of sensitization and of the neurochemical modi-
ﬁcations in the DARPP-32/PKA pathway, the expression of
DFosB was examined in the NAc of rats in the repeated saline
and repeated cocaine groups and in the repeated saline3m and
repeated cocaine3m groups, i.e. in rats killed after a 10-day or
3-month washout. Rats from the two experiments were killed
at the same time and tissues were processed simultaneously.
ANOVA analysis of the data revealed a signiﬁcant difference
between the groups (F3,19 = 15.60, p < 0.001). Post hoc
analysis indicated that the levels of DFosB expression were
increased in the repeated cocaine group compared to the
repeated saline group (p < 0.05, Fig. 6a, b, and c), while
DFosB expression was similar in the repeated cocaine3m and
repeated saline3m groups (Fig. 6a, d, and e). Moreover,
DFosB levels were higher in the repeated saline3m group
compared to those in the repeated saline group (p < 0.01,
Fig. 6a, b, and d). The anti-FosB antibody recognizes all
forms of FosB, but we assume that in sensitized rats the
increased immunostain represents DFosB as previous studies
have shown that DFosB, but not FosB or other Fos-related
antigens, is steadily expressed after repeated cocaine treat-
ment (Nestler 2001). However, we cannot be certain of the
identity of the immunoreactive FosB signal observed in the
NAc of repeated saline3m rats.
Discussion
The present study shows that a protocol of repeated cocaine
administration, that induced in rats a condition of clear-cut
behavioral sensitization, modiﬁed the pattern of DARPP-32
phosphorylation and the levels of Cdk5, GluR1, phospho-
GluR1, NR1, and phospho-NR1 in both the mPFC and NAc
after a short-term washout period (10 days). Moreover, after
a long-term washout (3 months) the expression of behavioral
sensitization was still present, although attenuated, and the
modiﬁcations in the same neurochemical markers were only
conserved to a certain extent. The present ﬁndings conﬁrmed
previous data obtained in rats with a different sensitization
protocol (40 mg/kg on alternate days for 14 days) (Scheggi
et al. 2004a,b).
Acute cocaine administration in sensitized rats elicited the
expected sensitized behavioral response, yet it did not affect
the pattern of modiﬁcations in DARPP-32, GluR1, and NR1
phosphorylation. This lack of effect was observed selectively
in the NAc, whereas DARPP-32 responsiveness to a 10 mg/
kg cocaine challenge was preserved in the mPFC. Only a
dose of 20 mg/kg of cocaine, double the efﬁcacious dose in
control rats, was able to decrease the levels of phospho-
Thr75 DARPP-32 and increase those of phospho-Thr34
DARPP-32 in the NAc of sensitized animals. Thus, the
increase in dopamine levels elicited by a 10 mg/kg cocaine
administration lacked the ability to increase PKA activity and
subsequently phospho-Thr34 DARPP-32 levels in the NAc
of cocaine-sensitized rats. These results suggest that the
pattern of DARPP-32 phosphorylation in the NAc of
cocaine-sensitized rats, characterized by high phospho-
Thr75 DARPP-32 levels, may exert an inhibitory effect on
PKA. Moreover, this blunted responsiveness of the PKA/
DARPP-32 pathway to acute cocaine administration could be
a neurochemical marker of the condition of cocaine sensi-
tization. We then attempted to elucidate the mechanism that
sustained the functional prevalence of phospho-Thr75 DAR-
PP-32 in cocaine-sensitized rats. Metabotropic glutamate
receptors have been reported to be involved in many of the
acute and chronic effects of cocaine exposure. Thus, cocaine
does not affect motility and does not induce self-administra-
tion in mGluR5 knock out mice (Chiamulera et al. 2001),
and mGluR1 and mGluR2/3 are involved in the increased
release of synaptic glutamate in the NAc and in the
reinstatement of cocaine seeking in rats extinguished from
cocaine self-administration (Kalivas et al. 2003). Metabo-
tropic glutamate receptors also play a direct role in DARPP-
32 phosphorylation, in particular, in neostriatal slices, the
activation of Cdk5 and phosphorylation of Thr75 DARPP-32
have been associated with the activation of type I mGluR
(Liu et al. 2001). Moreover, we have previously demon-
strated that a transient increase in phospho-Thr75 DARPP-32
levels, induced by palatable food consumption, is prevented
by the administration of MPEP, an antagonist of the mGluR5
subtype of type I mGluRs (Rauggi et al. 2005). Acute MPEP
administration to sensitized rats reinstated the levels of
phosphorylation of Thr75- and Thr34-DARPP-32 and of
GluR1 and NR1 subunits to the values of control animals. In
fact, MPEP signiﬁcantly reduced the levels of phospho-
Thr75 DARPP-32 and increased those of phospho-Thr34
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DARPP-32, phospho-GluR1, and phospho-NR1 subunits in
the mPFC and NAc of sensitized rats. These results suggest
that in cocaine-sensitized rats a tonic stimulation of mGluR5s
maintains DARPP-32 in the prevalent functional conforma-
tion of PKA inhibitor. In control rats, MPEP administration
had modest effects in the NAc, as only phospho-GluR1 levels
were increased; whereas, in the mPFC it decreased the levels
of phospho-Thr75 DARPP-32 and increased those of
phospho-Thr34 DARPP-32, phospho-GluR1, and phospho-
NR1. These results suggest that glutamatergic transmission in
the mPFC is characterized by a tonic stimulation of mGlu5
receptors. From a behavioral point of view, acute MPEP
administration did not signiﬁcantly modify the motor activity
of control and sensitized rats, but it reduced the sensitized
response to a cocaine challenge, thus suggesting that the
modiﬁed functional balance between the PKA inhibitory and
ampliﬁcatory forms of DARPP-32 is related to the condition
and expression of a cocaine-sensitized state. These data
support the hypothesis that increased phospho-Thr75 DAR-
PP-32 levels are strictly linked to the condition of cocaine
sensitization, and they are reminiscent of those obtained in
the mutant mice that cannot phosphorylate DARPP-32 at
Thr75 and do not develop cocaine sensitization (Zachariou
et al. 2006).
After the long-term (3 month) washout, behavioral
sensitization was less robustly expressed than after a
(a)
(b) (c)
(d) (e)
Fig. 6 Expression of DFosB in control and cocaine-sensitized rats
after a 10-day or 3-month washout. Cumulative data (number of
DFosB-like-immunoreactive cells) are shown in graphical format (a).
Photomicrographs of DFosB-like-immunoreactive cells in the NAc of
control and cocaine-sensitized rats after a 10-day [repeated saline10d
(b); repeated cocaine10d (c)] or 3-month washout [repeated saline3m
(d), repeated cocaine3m (e)]. Original magnification: 20·. **p < 0.01,
*p < 0.05 versus the repeated saline10d group (Bonferroni’s test).
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short-term washout, as horizontal locomotor activity was
still signiﬁcantly increased while stereotypy scores were
similar to those of control rats. Different results have been
reported in terms of persistence of cocaine sensitization,
from 1–2 months up to 6 months (Henry and White 1995;
Hope et al. 2006). These results are probably related to
differences in the sensitization treatment regimen chosen
(repeated cocaine administration in the home-cage vs.
novel-environment, variability in the dose of cocaine,
number of administrations, and interval between adminis-
trations), but also in the different criteria selected for the
assessment of sensitization (e.g. stereotypies vs. horizontal
locomotor activity).
After the 3-month washout, the DARPP-32 phosphoryla-
tion pattern and GluR1, phospho-GluR1, NR1, phospho-NR1,
and Cdk5 levels were similar to those observed in age-
matched control rats, in both the mPFC and NAc. It should
be noted that when basal phospho-Thr75 DARPP-32 levels
reached control values, the levels of Cdk5 expression were
decreased, in agreement with the proposed role of this kinase
as a negative regulator of dopamine transmission in cocaine-
sensitized animals (Taylor et al. 2007). The responsiveness
of the DARPP-32 system to a cocaine challenge was still
unmodiﬁed in the mPFC. In the NAc, the response to an
acute cocaine challenge was only partially restored, com-
pared to the response of age-matched control rats. In fact,
phospho-Thr75 DARPP-32 levels decreased and phospho-
GluR1 and phospho-NR1 levels increased, although to a
lesser extent than in control rats, while phospho-Thr34
DARPP-32 levels were unmodiﬁed. Finally, the levels of
DFosB-like proteins in the NAc were similar to those in the
age-matched control group. Moreover, the levels of DFosB-
like immunoreactivity in the control animals of the 3-month
washout experiment were higher than those in the control
animals of the 10-day washout experiment. A progressive
developmental increase in DFosB-like expression in the NAc
during the post-weanling, periadolescent, and adult ages has
been described in mice (Ehrlich et al. 2002); however, a
thorough study of DFosB-like protein levels as a function of
aging has not been performed. Thus, we do not know
whether aging alone and/or other factors in our experimental
conditions contributed to the observed induction of DFosB-
like levels.
In conclusion, behavioral sensitization to cocaine is a
long-lasting, yet transient phenomenon, at least in our
experimental setting, and we have shown that the neuro-
chemical modiﬁcations that characterize the condition of
sensitization and the sensitized behavioral response to
cocaine have a similar temporal pattern. In particular, after
a 10-day washout, the behavioral expression of sensitization
was accompanied by neurochemical modiﬁcations in the
dopamine D1 receptor/DARPP-32/PKA pathway, and after a
3-month washout, both the behavioral expression and the
neurochemical modiﬁcations were still present, but in an
attenuated form. Thus, the present data support the correla-
tion between the condition of cocaine-induced behavioral
sensitization and a tonic increase in the levels of phospho-
Thr75 DARPP-32 that inhibits PKA activity. This increase
was sustained by mGluR5 stimulation, leading to complex
neuroadaptation processes that lasted as long as behavioral
sensitization.
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